Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Modifying Factors and Pheochromocytomas in Multiple Endocrine Neoplasia Type 2

NCT05158712 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT05158712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05158712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Modifying Factors and Pheochromocytomas in Multiple Endocrine Neoplasia Type 2
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Observational
Overall status
Unknown status
Start date
February 2, 2022
Completion date
December 14, 2023
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasia, pheochromocytoma